Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    European journal of clinical pharmacology 36 (1989), S. 495-499 
    ISSN: 1432-1041
    Keywords: propafenone ; uraemia ; alpha1-acid glycoprotein ; equilibrium dialysis ; binding ratio ; unbound fraction ; serum protein binding
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology , Medicine
    Notes: Summary The protein binding of propafenone, a Class I antiarrhythmic agent, was studied in vitro using a selective and sensitive electron-capture detection gas-liquid capillary chromatographic assay method developed in our laboratory. The concentration-dependency of the serum protein binding of propafenone was confirmed in vitro by equilibrium dialysis, using serum obtained from healthy human subjects and patients with chronic renal failure. In normal serum the unbound fraction of propafenone was 0.027 at a propafenone concentration of 0.25 µg · ml−1, 0.041 within the therapeutic concentration range (0.5–2 µg · ml−1), 0.138 at a propafenone concentration of 25 µg · ml−1, and 0.187 when the propafenone concentration was increased to 100 µg · ml−1. There was no evidence of significant concentration-dependent changes in unbound fraction within the propafenone concentration range of 0.5–1.5 µg · ml−1. However, concentration-dependent binding was demonstrated at concentrations greater than 1.5 µg · ml−1. A high-affinity, low-capacity binding site (K1=6.53×105 l · mol−1; n1P1=1.73×10−4 mol · l−1) and a low-affinity, high-capacity binding site (K2=8.77×103 l · mol−1; n2P2=8.57×10−3 mol · ×l−1) were identified. In pooled uraemic serum the unbound fraction of propafenone was approximately 50% of that of normal serum throughout the concentration range studied (1–5 µg · ml−1). In sera from patients with chronic renal failure the increase in propafenone binding ratio or the decrease in unbound fraction was associated with the increase in alpha1-acid glycoprotein concentrations, and there was a correlation (r=0.8302) between alpha1-acid glycoprotein concentration and the propafenone binding ratio.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1432-1041
    Keywords: tocainide ; uraemia ; enantiomers ; stereoselective ; pharmacokinetics
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology , Medicine
    Notes: Summary The disposition of tocainide enantiomers were examined in healthy human subjects and uraemic patients following a single i. v. dose (200 mg) of racemic tocainide hydrochloride. In the healthy subjects, the total body clearance of R(−)-tocainide was significantly greater than that of S(+)-tocainide (2.62 vs 1.70 ml·min−1·kg−1). Renal clearance also favoured R(−)-tocainide and appeared to contribute significantly to the stereoselective total body clearance. The volume of distribution of the enantiomers did not differ significantly. Uraemia produced a marked decrease in the total body clearance with no apparent effect on the volume of distribution of both enantiomers. The S/R ratio for total body clearance decreased significantly from 0.66 in healthy subjects to 0.54 in the uraemics, while the ratio for terminal elimination half-life significantly increased from 1.43 to 1.59. These results indicate that uraemia alters the degree of stereoselectivity in the pharmacokinetic parameters of tocainide enantiomers.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...